Mehmet Fatih Yetkin

Fingolimod Alters Tissue Distribution and Cytokine Production of Human and Murine Innate Lymphoid Cells

Ahmet Eken, Mehmet Fatih Yetkin, Alperen Vural et al. · Frontiers in Immunology · 2019 · 40 citations · Full text

The outcome of a national MS-Covid-19 study: What the Turkish MS cohort reveals?

Sedat Şen, Rana Karabudak, Irene Schiavetti et al. · Multiple Sclerosis and Related Disorders · 2021 · 23 citations · Full text

Epidemiological Trend, Epidemiological Outcome, National Ms-covid-19 Study +5

The role of exercise in migraine treatment.

Emel Köseoğlu, Mehmet Fatih Yetkin, Feti Ahmet Uğur et al. · PubMed · 2015 · 22 citations

Physical Activity, Kinesiology, Exercise +17

The comparative effectiveness of fingolimod, natalizumab, and ocrelizumab in relapsing-remitting multiple sclerosis

Cavit Boz, Serkan Özakbaş, Murat Terzi et al. · Neurological Sciences · 2023 · 18 citations · Full text

Neutrophil to-lymphocyte ratio as a possible predictor of prognosis in recently diagnosed multiple sclerosis patients

Mehmet Fatih Yetkin, Meral Mirza · Journal of Neuroimmunology · 2020 · 16 citations

Multiple Sclerosis Patients, Autoimmune Disease, Disease Progression +14